Contribution of Glucosylsphingosine (Lyso-Gb1) to Treatment Decisions in Patients with Gaucher Disease

Glucosylsphingosine (lyso-Gb1), the deacylated form of glucocerebroside, was shown to be the most specific and sensitive biomarker for diagnosing Gaucher disease (GD). The aim of this study is to assess the contribution of lyso-Gb1 at the time of diagnosis for treatment decisions in naïve patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinur, Tama, Bauer, Peter, Beetz, Christian, Cozma, Claudia, Becker-Cohen, Michal, Istaiti, Majdolen, Rolfs, Arndt, Skrahina, Volha, Zimran, Ari, Revel-Vilk, Shoshana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966520/
https://www.ncbi.nlm.nih.gov/pubmed/36835356
http://dx.doi.org/10.3390/ijms24043945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966520/
https://www.ncbi.nlm.nih.gov/pubmed/36835356
http://dx.doi.org/10.3390/ijms24043945

Ejemplares similares